Cell & Gene Therapies — Manufacturers, Suppliers & Exporters
PharmaTradz lists 10 Cell & Gene Therapies products from verified GMP-certified manufacturers, suppliers and exporters worldwide, available as Iv Infusion, Intravenous Infusion, Injectable Gene Therapy, Subretinal Injection and more. Commonly sourced molecules include Onasemnogene abeparvovec Injectable, Axicabtagene Ciloleucel Infusion, Etranacogene dezaparvovec. infusion. Buyers can compare specifications, request bulk quotes, and source with regulatory documentation (COA, GMP certificates, CTD/ACTD dossiers) for import into their market.
Available dosage forms
Iv Infusion (4) Intravenous Infusion (3) Injectable Gene Therapy (1) Subretinal Injection (1) Intralesional Injection (1)Reference brands in this category
Kymriah Yescarta Breyanzi Abecma Zolgensma Luxturna Roctavian Skysona Hemgenix AlofiselSend us an RFP — our team sources it from verified manufacturers and reverts with quotes.
Browse Cell & Gene Therapies products
Axicabtagene Ciloleucel Infusion
Strength: Single infusion treatment approved for relapsed/refractory large B-cell lymphoma, with dosing based on patient weight
Form: IV Infusion
Reference Brands: Yescarta (US & EU)
View Details Get Enquiry
Ciltacabtagene autoleucel infusion
Strength: Approved for relapsed/refractory multiple myeloma, with a targeted dose individualized based on patient weight
Form: IV Infusion
Reference Brands:
View Details Get Enquiry
Darleukin Injection
Strength: A standardized dose of 120 million adipose-derived stem cells per injection
Form: Intralesional injection
Reference Brands: Alofisel(US & EU)
View Details Get Enquiry
Elivaldogene autotemcel Infusion
Strength: A personalized gene therapy designed to halt or slow ALD progression, dosed based on weight, administered as a single infusion in specialized treatment centers
Form: Intravenous infusion
Reference Brands: Skysona(US & EU)
View Details Get Enquiry
Etranacogene dezaparvovec. infusion
Strength: Single infusion product designed to produce sustained factor IX levels in hemophilia B patients, dosage individualized based on patient weight
Form: Intravenous infusion
Reference Brands: Hemgenix (US & EU)
View Details Get Enquiry
Idecabtagene Vicleucel Infusion
Strength: Approved for relapsed/refractory multiple myeloma, with dosing based on patient weight, delivering a personalized, targeted therapy to eliminate cancer cells
Form: IV Infusion
Reference Brands: Abecma(US & EU)
View Details Get Enquiry
Lisocabtagene maraleucel Infusion
Strength: Approved for relapsed/refractory large B-cell lymphoma, with a standard dose of 100 million CAR T cells per infusion
Form: IV Infusion
Reference Brands: Breyanzi (US & EU)
View Details Get Enquiry
Onasemnogene abeparvovec Injectable
Strength: Single-dose IV infusion providing 6 x 10^13 vector genomes (vg) per patient
Form: Injectable gene therapy
Reference Brands: Zolgensma(US & EU)
View Details Get Enquiry
Tisagenlecleucel Infusion
Strength: Single infusion, approved for relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL)
Form: IV Infusion
Reference Brands: Kymriah(US & EU)
View Details Get Enquiry
valoctocogene roxaparvovec Infusion
Strength: A single-dose gene therapy designed to increase factor VIII production in hemophilia A patients
Form: Intravenous infusion
Reference Brands: Roctavian(US & EU)
View Details Get Enquiry
voretigene neparvovec Infusion
Strength: Adeno-associated virus (AAV) vector administered via subretinal injection
Form: Subretinal injection
Reference Brands: Luxturna(US & EU)
View Details Get Enquiry